HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Other Abstracts

291 - Predictors and Clinical Outcomes of Lymphoproliferative Disorders in Heart Transplant Recipients

Presentation Number
291
Speakers
Session Name
SESSION 75 - ORAL: Cancer after Heart Transplant: The Phantom Menace
Date
Sat, Apr 25, 2020
Time
08:15 AM - 10:00 AM
Authors

Previous ePresentation
290 - De Novo Malignancy after Heart Transplantation

Next ePresentations
297 - Stroke in Pediatric Ventricular Assist Device Patients-A PediMACS Registry Analysis
299 - Inflammatory Responses in Pediatric Patients with Suspected Myocarditis
301 - T1 Mapping and Conditional Survival in Pediatric Dilated Cardiomyopathy with Advanced Heart Failure
303 - Association between Angiotensin II Antagonism and Mortality after LVAD Implantation: A Multi-Center, Contemporary Analysis
304 - The Effect of Renin-Angiotensin-Aldosterone System Inhibition on Morbidity and Mortality during Long-Term Continuous-Flow Left Ventricular Assist Device Support
306 - Partial Recovery of Ejection Fraction with Neurohormonal Blockade Improves Long-Term Event Free Survival for Patients with Continuous Flow LVAD
307 - The Depolarization Amplitude of the Electromyogram is a Measure of End-Diastolic Ventricular Volume
308 - Feasibility and Patient Perceptions of Tele-Videoconferencing Visits for LVAD Patients (TeleLVAD Study)
311 - Ischemia and Reperfusion Injury in Donation after Circulatory Death Heart: Role of Interleukin-1
316 - Utilization of New Heart Preservation Technology in the Era of New Organ Allocation and Extended Ischemic Times